TriSalus Life Sciences Inc
TLSI7.080USD
-0.380-5.09%
Market hours （ET）Quotes delayed by 15 min
353.23MMarket Cap
LossP/E TTM
TriSalus Life Sciences Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
29.43M
58.99%
EPS(YoY)
-1.31
80.62%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its total revenue reached 29.43M, with a year-on-year change of 58.99%.
What is the Earnings Per Share (EPS) of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.312, with a year-on-year change of 80.62%.
What is the net income of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its net income was -33.23M, with a year-on-year change of 47.75%.
What is the net margin of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its net profit margin was -102.09%, with a year-on-year change of 68.17%.
What is the gross margin of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its gross margin was 86.06%, with a year-on-year change of 0.15%.
What is the debt-to-asset ratio of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its debt-to-asset ratio was 92.53%, with a year-on-year change of 14414.04%.
What is the Return on Equity (ROE) of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.
What is the Return on Assets (ROA) of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its Return on Assets (ROA) was -123.72%, with a year-on-year change of 51.45%.
What is the operating profit of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its operating profit was -36.16M, with a year-on-year change of 33.61%.
What are the current assets of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its current assets were 20.67M, with a year-on-year change of -0.93%.
What are the total assets of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its total assets of TriSalus Life Sciences Inc were 23.97M, with a year-on-year change of -2.55%.
What are the total liabilities of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its total liabilities of TriSalus Life Sciences Inc were 49.87M, with a year-on-year change of -3.48%.
What is the total equity of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its total equity of TriSalus Life Sciences Inc was -25.89M, with a year-on-year change of 4.33%.
What is the net operating income of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its net operating income of TriSalus Life Sciences Inc was -30.05M, with a year-on-year change of 49.39%.
What is the net investment of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its net investment of TriSalus Life Sciences Inc was -345.00K, with a year-on-year change of 78.27%.
What is the net financing of TriSalus Life Sciences Inc?
According to TriSalus Life Sciences Inc's FY2024 earnings report, its net financing of TriSalus Life Sciences Inc was 37.94M, with a year-on-year change of -30.56%.
